Alto Neuroscience Inc. Share Price

Alto Neuroscience Inc. Share Price

NYSE: ANRO | Small Cap
$23.80
+$0.44 (1.86%) Last updated on 29 Oct, 2026 | 20:38 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alto Neuroscience Inc. Stock Performance

Open
$23.67
Prev. Close
$23.36
Circuit Range
N/A
Day Range
$23.67 - $24.02
Year Range
$10.61 - $37.16
Volume
2,674
Average Traded
$23.78

Alto Neuroscience Inc. Share Price Today

As of 29 October 2026, Alto Neuroscience Inc.'s share price is $23.80. The stock opened at $23.67, compared to its previous close of $23.36. During today's trading session, Alto Neuroscience Inc.'s share price traded between $23.67 and $24.02, with an average price of $23.84. Over the past 52 weeks, the stock has recorded a high of $37.16 and a low of $10.61. In terms of performance, Alto Neuroscience Inc.'s share price has declined by 7.59% over the last six months and is up 67.51% on a year-on-year basis.

Alto Neuroscience Inc. Share Price Chart

Line chart of the Alto Neuroscience Inc. price trend over the selected period. The price rose overall, ranging from 23.25 to 24.02, ending at 23.80.
$23.67$24.02
L
Show Current Price
H

Alto Neuroscience Inc. Stock Fundamentals & Key Indicators

Market Cap
$686.53M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.15
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.42%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-94.92%

Alto Neuroscience Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.18-$16.18-$26.24-$27.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.10%-62.18%-5.34%

Alto Neuroscience Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$61.43-$63.24
Net Profit MarginN/AN/A
Income ChangeN/A-2.95%

About Alto Neuroscience Inc.

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$25.87
$23.84
-6.93%
Sep 2026
$36.02
$25.62
-29.32%
Aug 2026
$26.65
$36.25
+33.76%
Jul 2026
$26.29
$27.10
+2.57%
Jun 2026
$20.05
$26.42
+31.57%
May 2026
$25.26
$20.08
-22.02%
Apr 2026
$22.57
$25.75
+14.17%
Mar 2026
$19.16
$22.55
+15.19%
Feb 2026
$14.59
$19.58
+26.73%
Jan 2026
$17.57
$15.45
-13.32%
Dec 2025
$13.27
$17.82
+29.03%
Nov 2025
$14.10
$13.81
-2.75%

ANRO Share Price FAQs